Skip to main content
Top
Published in: Clinical Rheumatology 12/2014

01-12-2014 | Letter to the Editor

Suggested statistical reappraisal of data from comparative study of febuxostat and allopurinol in chronic kidney disease

Author: Alan Zelicoff

Published in: Clinical Rheumatology | Issue 12/2014

Login to get access

Excerpt

To the Editor: …
Literature
1.
go back to reference Tsuruta Y, Mochizuki T, Moriyama T, Itabashi M, Takei T, Tsuchiya K, et al (2014) Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease. Clin Rheumatol. doi:10.1007/s10067-014-2745-5 Tsuruta Y, Mochizuki T, Moriyama T, Itabashi M, Takei T, Tsuchiya K, et al (2014) Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease. Clin Rheumatol. doi:10.​1007/​s10067-014-2745-5
2.
go back to reference Shibagaki Y, Ohno I, Hosoya T, Kimura K (2014) Safety, efficacy and renal effect of febuxostat in patients with moderate-to-severe kidney dysfunction. Hypertens Res Off J Jpn Soc Hypertens. doi:10.1186/1745-6215-15-26 Shibagaki Y, Ohno I, Hosoya T, Kimura K (2014) Safety, efficacy and renal effect of febuxostat in patients with moderate-to-severe kidney dysfunction. Hypertens Res Off J Jpn Soc Hypertens. doi:10.​1186/​1745-6215-15-26
3.
go back to reference Hosoya T, Kimura K, Itoh S, Inaba M, Uchida S, Tomino Y et al (2014) The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study. Trials 15:26PubMedCentralPubMedCrossRef Hosoya T, Kimura K, Itoh S, Inaba M, Uchida S, Tomino Y et al (2014) The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study. Trials 15:26PubMedCentralPubMedCrossRef
4.
go back to reference Glantz SA (2012) Primer of Biostatistics. McGraw-Hill, New York Glantz SA (2012) Primer of Biostatistics. McGraw-Hill, New York
Metadata
Title
Suggested statistical reappraisal of data from comparative study of febuxostat and allopurinol in chronic kidney disease
Author
Alan Zelicoff
Publication date
01-12-2014
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 12/2014
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2788-7

Other articles of this Issue 12/2014

Clinical Rheumatology 12/2014 Go to the issue